Stockreport

Histogenics faces delisting from Nasdaq; shares down 5% [Seeking Alpha]

HISTOGENICS CORP COMMON  (HSGX) 
Last histogenics corp common earnings: 8/9 04:11 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.histogenics.com
PDF Thinly traded nano cap Histogenics ( HSGX ) receives a deficiency notice from Nasdaq citing its failure to maintain a minimum market value of $50M over 30 cons [Read more]